5 years ago

AVIDA Global Secures £1.6 Million to Expand Medicinal Cannabis Operations in Europe

  • AVIDA Global, a UK-based medicinal cannabis company, has raised £1.6 million in funding to expand its operations and sell its products to pharmaceutical companies across Europe

  • The company faces challenges in the UK due to a lack of understanding and prescription of medicinal cannabis by doctors

  • However, AVIDA Global believes the market is growing and the NHS will eventually follow the example of the private sector, which is seeing a surge in cannabis prescriptions.

      • ProblemHealthcare

      "There's a massive unmet need for effective pain relief, anxiety treatment, and solutions for post-traumatic stress and dietary issues, but traditional treatments aren't always cutting it. The problem is that medicinal cannabis, a potential solution, is facing resistance from doctors and the NHS due to stigma and lack of understanding, even though it's legal in the UK."

      Solution

      "AVIDA Global is tackling this by growing high-quality, pharmaceutical-grade medicinal cannabis in Colombia and partnering with pharmaceutical companies to get their products to patients. They're also raising awareness about the benefits of medicinal cannabis and educating healthcare professionals to overcome the stigma and create a more receptive environment for prescription."

      Covered on